(a) IN GENERAL- Section 1842(o)(1)(G) (42 U.S.C.
1395u(o)(1)(G)), as added by section 303(b), is amended to read as follows:
`(G) In the case of inhalation drugs or biologicals furnished through
durable medical equipment covered under section 1861(n) that are
furnished--
`(i) in 2004, the amount provided under paragraph (4) for the drug or
biological; and
`(ii) in 2005 and subsequent years, the amount provided under section
1847A for the drug or biological.'.
(b) GAO STUDY OF MEDICARE PAYMENT FOR INHALATION
THERAPY-
(1) STUDY- The Comptroller General
of the United States shall conduct a study to examine the adequacy of current
reimbursements for inhalation therapy under the medicare program.
(2) REPORT- Not later than 1 year after
the date of the enactment of this Act, the Comptroller General shall submit
to Congress a report on the study conducted under paragraph (1).
